Search results
Data-Based Insights About Merck & Co Inc
Stocks Register· 14 hours agoMerck & Co Inc (NYSE:MRK) price on Thursday, May 09, rose 0.08% above its previous day’s close as an upside momentum from buyers pushed the stock ...
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks via Yahoo Finance· 8 hours agoThe Zacks Value Style Score...better than a C; and so on), is pretty helpful in identifying whether...
Dow Jones Falls After Jobless Claims Jump; Airbnb, Arm, Roblox Plunge On Earnings
Investor's Business Daily· 7 hours agoChipotle and Merck featured in this Stocks Near A Buy Zone column. An essential resource for daily...
Dow Jones Falls As Tesla Slides On Autopilot Fraud Probe; Uber Dives On Surprise Loss
Investor's Business Daily· 1 day agoChipotle and Merck featured in this Stocks Near A Buy Zone column. An essential resource for daily...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 hours agoMerck just won approval for the first drug that treats an underlying cause of PAH, Winrevair. Like...
Dow Jones Futures Rise: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Investor's Business Daily· 2 days agoOnce again, the Nasdaq's strong price gain came on slightly lower volume, but the panel explained...
Dow Jones Rises As Disney Dives On Sales Miss; Palantir Plunges On Earnings
Investor's Business Daily· 2 days agoOnce again, the Nasdaq's strong price gain came on slightly lower volume, but the panel explained...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 6 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
Zacks via Yahoo Finance· 8 hours agoRevenues of $997.4 million outpaced the consensus mark by 2.6%. You can see the complete list of ...
CytomX stock down 30% despite encouraging cancer study results | Invezz
Invezz· 8 hours agoCytomX Therapeutics Inc reported favourable results for its ongoing trial of CX-904 on Thursday. Are...
